SCHEMBL6582183

SCHEMBL6582183

Clc1ccc(C(c2ccccc2)N2CCNC(CCOc3ccccc3)C2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 4/20 0.43
CYP19A1 P11511 1/20 0.43
DRD3 P35462 4/20 0.42
KCNH2 Q12809 4/20 0.42
CHRM2 P08172 3/20 0.42
ADRA2A P08913 3/20 0.42
ADRA1A P35348 3/20 0.42
SLC6A2 P23975 3/20 0.42
SLC6A4 P31645 3/20 0.42
SLC6A3 Q01959 3/20 0.42
HTR1A P08908 2/20 0.42
CHRM1 P11229 2/20 0.42
DRD1 P21728 2/20 0.42
TBXA2R P21731 2/20 0.42
BCL2 P10415 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
HRH1 P35367 4/20 0.42
USP2 O75604 3/20 0.42
HRH2 P25021 2/20 0.42
HTR2A P28223 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6631216 0.85 HRH1 (0.58) CYP2D6CYP19A1DRD3KCNH2CHRM2
SCHEMBL3242570 0.83 CYP2D6 (0.41) CYP2D6CYP19A1DRD3KCNH2CHRM2
SCHEMBL23724037 0.83 HRH1 (0.60) CYP2D6DRD3KCNH2CHRM2ADRA2A
SCHEMBL3243434 0.83 HRH1 (0.60) CYP2D6DRD3KCNH2CHRM2ADRA2A
SCHEMBL4431100 0.83 SLC6A9 (0.45) CYP2D6DRD3KCNH2CHRM2ADRA2A
SCHEMBL14034041 0.82 CYP2D6 (0.48) CYP2D6CYP19A1DRD3KCNH2CHRM2
Hydrochloric Acid SCHEMBL6951585 0.82 HRH1 (0.45) CYP2D6DRD3KCNH2CHRM2ADRA2A
Hydrochloric Acid SCHEMBL3818204 0.82 HRH1 (0.60) CYP2D6DRD3KCNH2CHRM2ADRA2A
Hydrochloric Acid SCHEMBL21462452 0.82 HRH1 (0.45) CYP2D6DRD3KCNH2CHRM2ADRA2A
Hydrochloric Acid SCHEMBL5686146 0.82 HRH1 (0.45) CYP2D6DRD3KCNH2CHRM2ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165533-B1 COMPOUNDS AND METHODS FOR TREATMENT OF ASTHMA, ALLERGY AND INFLAMMATORY DISORDERS UCB SA (BE) 2004-10-13 EP disclosed
EP-1418173-A1 N-(3-butyn-1-yl) N-hydroxyurea UCB, S.A. (BE) 2004-05-12 EP disclosed